24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Importance of Extranuclear Estrogen Receptor-α and Membrane G Protein–Coupled Estrogen Receptor in Pancreatic Islet Survival

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          OBJECTIVE

          We showed that 17β-estradiol (E 2) favors pancreatic β-cell survival via the estrogen receptor-α (ERα) in mice. E 2 activates nuclear estrogen receptors via an estrogen response element (ERE). E 2 also activates nongenomic signals via an extranuclear form of ERα and the G protein–coupled estrogen receptor (GPER). We studied the contribution of estrogen receptors to islet survival.

          RESEARCH DESIGN AND METHODS

          We used mice and islets deficient in estrogen receptor-α (αERKO −/−), estrogen receptor-β (βERKO −/−), estrogen receptor-α and estrogen receptor-β (αβERKO −/−), and GPER (GPERKO −/−); a mouse lacking ERα binding to the ERE; and human islets. These mice and islets were studied in combination with receptor-specific pharmacological probes.

          RESULTS

          We show that ERα protection of islet survival is ERE independent and that E 2 favors islet survival through extranuclear and membrane estrogen receptor signaling. We show that ERβ plays a minor cytoprotective role compared to ERα. Accordingly, βERKO −/− mice are mildly predisposed to streptozotocin-induced islet apoptosis. However, combined elimination of ERα and ERβ in mice does not synergize to provoke islet apoptosis. In αβERKO −/− mice and their islets, E 2 partially prevents apoptosis suggesting that an alternative pathway compensates for ERα/ERβ deficiency. We find that E 2 protection of islet survival is reproduced by a membrane-impermeant E 2 formulation and a selective GPER agonist. Accordingly, GPERKO −/− mice are susceptible to streptozotocin-induced insulin deficiency.

          CONCLUSIONS

          E 2 protects β-cell survival through ERα and ERβ via ERE-independent, extra-nuclear mechanisms, as well as GPER-dependent mechanisms. The present study adds a novel dimension to estrogen biology in β-cells and identifies GPER as a target to protect islet survival.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          beta-Cell death during progression to diabetes.

          The hallmark of type 1 diabetes is specific destruction of pancreatic islet beta-cells. Apoptosis of beta-cells may be crucial at several points during disease progression, initiating leukocyte invasion of the islets and terminating the production of insulin in islet cells. beta-Cell apoptosis may also be involved in the occasional evolution of type 2 into type 1 diabetes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Virtual and biomolecular screening converge on a selective agonist for GPR30.

            Estrogen is a hormone critical in the development, normal physiology and pathophysiology of numerous human tissues. The effects of estrogen have traditionally been solely ascribed to estrogen receptor alpha (ERalpha) and more recently ERbeta, members of the soluble, nuclear ligand-activated family of transcription factors. We have recently shown that the seven-transmembrane G protein-coupled receptor GPR30 binds estrogen with high affinity and resides in the endoplasmic reticulum, where it activates multiple intracellular signaling pathways. To differentiate between the functions of ERalpha or ERbeta and GPR30, we used a combination of virtual and biomolecular screening to isolate compounds that selectively bind to GPR30. Here we describe the identification of the first GPR30-specific agonist, G-1 (1), capable of activating GPR30 in a complex environment of classical and new estrogen receptors. The development of compounds specific to estrogen receptor family members provides the opportunity to increase our understanding of these receptors and their contribution to estrogen biology.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Gene regulation by steroid hormones.

                Bookmark

                Author and article information

                Journal
                Diabetes
                diabetes
                diabetes
                Diabetes
                Diabetes
                American Diabetes Association
                0012-1797
                1939-327X
                October 2009
                8 July 2009
                : 58
                : 10
                : 2292-2302
                Affiliations
                [1] 1Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University School of Medicine, Chicago, Illinois;
                [2] 2Department of Medicine, Division of Diabetes, Endocrinology & Metabolism, Baylor College of Medicine, Houston, Texas;
                [3] 3Department of Internal Medicine, Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, Texas;
                [4] 4National Institutes of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina.
                Author notes
                Corresponding author: Franck Mauvais-Jarvis, f-mauvais-jarvis@ 123456northwestern.edu .
                Article
                0257
                10.2337/db09-0257
                2750222
                19587358
                12dd1d4f-5f80-4dbb-9149-7159e3c0a20a
                © 2009 by the American Diabetes Association.

                Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

                History
                : 20 February 2009
                : 26 June 2009
                Funding
                Funded by: National Institutes of Health
                Award ID: RO1 DK074970
                Award ID: P50 HD044405
                Categories
                Original Article
                Islet Studies

                Endocrinology & Diabetes
                Endocrinology & Diabetes

                Comments

                Comment on this article